Targeting Lymphatic Vessel Activation and CCL21 Production by Vascular Endothelial Growth Factor Receptor-3 Inhibition Has Novel Immunomodulatory and Antiarteriosclerotic Effects in Cardiac Allografts

A. I Nykanen, H Sandelin, R Krebs, M. A. I Keranen, R Tuuminen, T Karpanen, Y Wu, B Pytowski, P. K Koskinen, S Yla Herttuala, K Alitalo and K. B. Lemstrom

Circulation 121 ( 12 ): 1413 - 1422 , 2010